Results 251 to 260 of about 60,819 (305)

Anaphylaxis after stings by <i>Vespula</i> spp. - preventions, safety profile of venom immunotherapy, data from the Anaphylaxis Registry for West Pomerania Voivodeship, Poland. [PDF]

Hum Vaccin Immunother
Poziomkowska-Gęsicka I, Rudnicka M, Gęsicki A, Zielska M, Safranow K.   +4 more
europepmc   +1 more source

Real-life safety of peanut oral immunotherapy: Results from a French multicenter observational study. [PDF]

J Allergy Clin Immunol Glob
Michaud E, Amat F, Lambert C, Divaret-Chauveau A, Deschildre A, Peanut Oral Immunotherapy Working Party from the French Society of Allergology.   +5 more
europepmc   +1 more source

T‐cell immunomodulation occurs with different time kinetics during acalabrutinib and zanubrutinib therapy in chronic lymphocytic leukaemia

British Journal of Haematology, EarlyView.
Maria L. Andersson, Olina Lind, Kia Heimersson, Anna Berglöf, Teresa del Peso Santos, Lucía Peña‐Pérez, Qing Wang, Tom A. Mulder, Rula Zain, Robert Månsson, Richard Rosenquist, C. I. Edvard Smith, Anders Österborg, Marzia Palma   +13 more
wiley   +1 more source

Variation in pediatric egg and milk allergy management: A multinational survey in Ireland, Spain, and Canada. [PDF]

Pediatr Allergy Immunol
Gallagher A, Protudjer JLP, Mack DP, de Los Angeles Gonzalez Labrador M, Muñoz C, Cronin C, Trujillo J.   +6 more
europepmc   +1 more source

SUBDUE‐3: SUB‐urothelial DUrvalumab‐89zirconium injEction; a phase 0 biodistribution study protocol

BJU International, EarlyView.
Kevin G. Keane, Richard Gauci, Roslyn J. Francis, Andrew M. Scott, Cynthia Hawks, Andrisha‐Jade Inderjeeth, Ian D. Davis, Jayne Lim, Andrew Redfern, Dickon Hayne   +9 more
wiley   +1 more source

The Drop of Allergen Immunotherapy for Respiratory Allergy in Italy: An Assessment of Sales. [PDF]

Clin Exp Allergy
Giovannini M, Bognanni A, Barbaglia S, Brussino L, Caruso C, Catamerò F, Gargano D, Heffler E, Paoletti G, Canonica GW.   +9 more
europepmc   +1 more source

Dosing Reactions and Missed Doses Affect Peanut Oral Immunotherapy Outcomes. [PDF]

J Allergy Clin Immunol Pract
Olayiwola O, Mudd L, Dunaway L, Laidlaw TM, Jones SM, Fulkerson PC, Sanda S, Huffaker MF.   +7 more
europepmc   +1 more source

Early Walnut Powder Introduction for Prevention of Walnut Sensitisation in High‐Risk Infants With Eczema: An Open‐Label, Randomised, Non‐Inferiority Trial

Clinical &Experimental Allergy, EarlyView.
Sayaka Hamaguchi, Mayako Saito‐Abe, Mami Shimada, Hisako Ogasawara, Chisato Jimbo, Tomoki Yaguchi, Daisuke Harama, Daichi Suzuki, Kotaro Umezawa, Seiko Hirai, Kenji Toyokuni, Osamu Natsume, Fumiya Yamaide, Chikako Motomura, Tatsuki Fukuie, Yukihiro Oyha, Kiwako Yamamoto‐Hanada   +16 more
wiley   +1 more source

Engineering Chimeric Hypoallergens for Safer and More Effective House Dust Mite Allergy Vaccines

Clinical &Experimental Allergy, EarlyView.
Eduardo S. da Silva, Antônio M. S. Fernandes, Elisânia F. Silveira, Raphael C. Silva, Leonardo F. Santiago, Luis F. S. Garcés, Sara Huber, Sabrina Wildner, Tafarel A. Souza, Vitor S. Alves, Lorena M. de Souza, Deise S. Vilas‐Bôas, Peter Briza, Peter Lackner, Luis G. C. Pacheco, Neuza M. Alcântara‐Neves, Fatima Ferreira, Carina S. Pinheiro   +17 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Immunotherapy for food allergy

Current Opinion in Otolaryngology & Head & Neck Surgery, 2017
Purpose of review The current review discusses strategies for administering specific immunotherapy (SIT) for the treatment of food allergy. It focuses on three delivery routes for food allergens, immunomodulatory adjuvants and allergen modifications.
William R, Reisacher, Wesley, Davison
openaire   +2 more sources